<DOC>
	<DOCNO>NCT01396447</DOCNO>
	<brief_summary>The objective study evaluate efficacy , safety , tolerability cariprazine relative placebo treatment patient bipolar depression .</brief_summary>
	<brief_title>Safety , Tolerability , Efficacy Cariprazine Patients With Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Patients provide informed consent prior study specific procedure . Patients currently meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criteria bipolar I disorder confirm Structured Clinical Interview ( SCID ) DSMIVTR bipolar I depression without psychotic feature . Patients normal physical examination , laboratory , vital sign , and/ echocardiogram ( ECG ) . Verified previous manic mixed episode . Patients total Hamilton Rating Scale Depression ( HAMD ) 17 score ≥ 20 . Patients HAMD17 item 1 score ≥ 2 . Patients Clinical Global Impression Severity ( CGIS ) score ≥ 4 . Patients DSMIVTR diagnosis axis I disorder bipolar I disorder primary focus treatment within previous 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Bipolar I Disorder</keyword>
	<keyword>Bipolar Depression</keyword>
	<keyword>Depression</keyword>
	<keyword>Bipolar Disorder</keyword>
</DOC>